DupuyAM, PhilippartF, PéanY, et al.Role of biomarkers in the management of antibiotic therapy: An expert panel review: I–currently available biomarkers for clinical use in acute infections. Ann Intensive Care, 2013; 3(1):1–8; doi: 10.1186/2110-5820-3-22
2.
GrossM. How to avoid a post-antibiotic age. Curr Biol, 2021; 31(24):R1549–R1552; doi: 10.1016/j.cub.2021.11.070
3.
HeffernanAJ, SimeFB, LipmanJ, et al.Individualising therapy to minimize bacterial multidrug resistance. Drugs, 2018; 78:621–641; doi: 10.1007/s40265-018-0891-9
4.
LvJ, DengS, ZhangL. A review of artificial intelligence applications for antimicrobial resistance. Biosaf Health, 2021; 3(01):22–31; doi: 10.1016/j.bsheal.2020.08.003
5.
VoermansAM, MewesJC, BroylesMR, et al.Cost-effectiveness analysis of a procalcitonin-guided decision algorithm for antibiotic stewardship using real-world US hospital data. OMICS, 2019; 23(10):508–515; doi: 10.1089/omi.2019.0113
